ACCP Txp PRN

Rounding out this month's #traineetakeover, 👩‍⚕️ Abbigale Hampton, PharmD is here with a review of recurrent autoimmune hepatitis! What is your favorite strategy to reduce ongoing risk for your patients? Tell us in the comments! #livertransplant #autoimmunedisease #accp

Bariatric surgery is more common than ever, and it results in some major differences in medication absorption. ✍️ Don't worry though, Abbigale Hampton, PharmD is here to share some tips for tacrolimus in this week's #traineetakeover! #accp #transplant #bariatricsurgery

How do you assess net immunosuppression in your patients? Torque teno virus is a promising biomarker that has been making waves! 🏄‍♀️In this week's #traineetakeover Abbigale Hampton shares a helpful review recent data. 💊Thanks, Abbigale! #accp #kidneytransplant #Immunosuppression

Its American Heart Month🫀and time for another #traineetakeover! Introducing Abbigale Hampton, PharmD! Abbigale is completing her PGY2 residency at Rush University Medical Center in Chicago, Illinois and has a great month of content in store. Welcome to the #txpharm family! 🎉

CNIs got your BP through the roof? 😮 Don't worry, Amy Bowles is here to help! She provides a quick guide on post-transplant hypertension in this week's #traineetakeover. What's your go-to first line agent? 💊 #accp #txppharm #Hypertensionmanagement

Does your center routinely use Elexacafor/Tezacaftor/Ivacaftor (ETI) post-lung transplantation? Check out this multi center study from van Gemert et al, published in JHLT Open, evaluating the use of ETI post-lung transplantation! #manuscriptmonday jhltopen.org/article/S2950-…

New year, new #traineetakeover! Introducing Amy Bowles, a PharmD Candidate recently completed an APPE rotation with our PRN's very own Social Media Committee Chair, Olivia Huber, PharmD, BCTXP! Amy has a great month of content ahead, so give her a warm welcome! #TxpPrn #ACCP

✨ Feature Friday: Jean Kim at Tampa General Hospital ✨

📣 Don't miss the ACCP/AST Joint Webinar on Alcohol Use Disorder in SOT, next Tuesday 1/14!

How does your center approach immunosuppression management in a gender diverse population? Check out this review on the management of GaHT, immunosuppression, and monitoring in a transgender, nonbinary, and gender diverse population doi.org/10.1111/petr.1… #manuscriptmonday

It's MMDx time! 🔬In the last #traineetakeover of 2024, Liam Furlong, PharmD introduces this innovative method of rejection surveillance in renal transplant recipients. Does your center use MMDx? 🕵️‍♂️Thanks for wrapping up this year, Liam! #accp #txprn #diagostics

🌟 Feature Friday: Kat Petersen at Emory University Hospital ✨

But are there symptoms though? 👩‍🔬One of #TxPharms most commonly asked questions! Liam Furlong, PharmD makes the decision on whether or not to treat a little easier to answer in this week's #traineetakeover on UTI management in transplant recipients💊 #accp #kidneytransplant

Does your center utilize alemtuzumab to treat TCMR in kidney transplant recipients? Check out this restrospective multicenter study comparing outcomes with alemtuzumab vs rATG! #manuscriptmonday doi.org/10.1111/ctr.70…

The fungus is among us! 🍄 In this week's #traineetakeover, Liam Furlong, PharmD provides an overview of donor derived scedosporium infections. Do your center's prophylaxis regimens cover scedosporium? 🗣 #accp #txprn #txpID

December is here already and so is a new #traineetakover! Liam Furlong, PharmD is a PGY1 resident at Sentara Norfolk General Hospital, and he has a month of excellent tips, tricks, and pearls in store.🎻🏎 Welcome to the #TxPharm family, Liam! #accp #txprn #pharmacyresidency

Happy Spotify Wrapped Day to those who celebrate #MemeWednesday

How does your center approach alternative PJP prophylaxis options in patients who cannot tolerate TMP-SMX? Check out this single center study by He, K et al. evaluating alternative PJP prophylaxis in solid organ transplant recipients! #manuscriptmonday doi.org/10.1111/tid.14…

Patients with sickle cell anemia have a unique set of risks associated with #kidneytransplant. Do you know how to manage them? Don't worry, Kaanan Shah, PharmD has your back with the final #traineetakeover of November. Thanks for a great month, Kaanan! #ACCP #TxpPRN

Is a moderate-intensity statin more effective than low-intensity statin for CAV prevention at 1 year post transplant? Check out this trial comparing atorvastatin vs pravastatin! #ManuscriptMonday doi.org/10.1111/ctr.70…